Pfizer Launches AF Journey Website To Improve Atrial Fibrillation Health Literacy
KUALA LUMPUR, Malaysia, Jan. 27, 2023 /PRNewswire/ -- Pfizer Malaysia launched the new Atrial Fibrillation (AF) awareness website, www.afjourney.com.my, together with the National Heart Association of Malaysia (NHAM) and Malaysia Stroke Council (MSC). Atrial Fibrillation is an irregular heartbeat where the heart may not pump enough oxygen-rich blood out to the body.The website sheds light on AF and the stroke connection and features Holographic Augmented Reality Videogram (H.A.R.V) for an immersive experience to visualize the innerworkings of Atrial Fibrillation.
"The website serves to educate patients and caregivers directly and is a useful tool for cardiologists, neurologists, and other HCPs to leverage when educating their patients. We are proud to be working with the NHAM and the MSC to expand access to information on AF, stroke, and other heart-related diseases," said Luksanawan Thangpaibool, Country Manager and Cluster Lead, Pfizer Malaysia, Brunei & Pakistan.
Dr Ma Soot Keng, Council Member from the National Heart Association of Malaysia shared, "Patient's health literacy is important to help catch symptoms early onm AF also takes a significant toll—not just on the patient but also on support system. We want patients to understand AF and the importance of early detection."
Professor Dr Hoo Fan Kee, the President of the Malaysia Stroke Council elaborated, "Studies have shown that AF increases the risk of stroke and is also associated with older age, male sex, hypertension, and ischaemic heart disease. AF imposes substantial morbidity burdens and poor health-related quality of life and significantly increases the risk of stroke."
The positive outcome of driving awareness through the website and H.A.R.V. is to ensure AF patients are easily identified and seek early health to avoid life threatening consequences. The cost burden from non-communicable diseases can also be reduced and managed in the coming years.
To learn more about Atrial Fibrillation, please visit https://www.afjourney.com.my.
About Pfizer: Breakthroughs That Change Patients' Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. To learn more, please visit us www.Pfizer.com.my and like us on Facebook at https://www.facebook.com/PfizerMY/.
Upcoming Life Sciences Events
- March 2023
- Zurich: Swiss Nordic Bio 2023
- April 2023
- Basel: Swiss Biotech Day 2023
- London: BioTrinity 2023
Latest company news
IR-Med to present at National Pressure Injury Advisory Panel 2023
GHIT Fund Announces New Investments: A Total of Approximately 260 Million Yen in Shionogi, Takeda Pharmaceutical for New Malaria Drug Development
IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY